REAL-WORLD TREATMENT PATTERNS AND OVERALL SURVIVAL AMONG FOLLICULAR LYMPHOMA PATIENTS: A SEER-MEDICARE ANALYSIS

被引：0
|
作者：
Yang, S. [1 ]
Bains, Chawla S. [1 ]
Zhang, G. [1 ]
Wang, A. [2 ]
Yu, J. [2 ]
Arnette, D. [2 ]
Navarro, F. R. [1 ]
Blaedel, J. [1 ]
Mutebi, A. [1 ]
机构：
[1] Genmab US Inc, Plainsboro, NJ USA
[2] AbbVie, N Chicago, IL USA
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
RWD17
引用
收藏
页码：S363 / S363
页数：1
相关论文
共 50 条
  • [41] Real-world experience of carfilzomib-associated cardiovascular adverse events: SEER-Medicare data set analysis
    Bishnoi, Rohit
    Xie, Zhigang
    Shah, Chintan
    Bian, Jiang
    Murthy, Hemant S.
    Wingard, John R.
    Farhadfar, Nosha
    CANCER MEDICINE, 2021, 10 (01): : 70 - 78
  • [42] A SEER-Medicare Analysis of Treatment Patterns and Outcomes in Patients with Myelodysplastic Syndromes Treated with Hypomethylating Agent
    Stein, Eytan
    Latremouille-Viau, Dominick
    Shi, Sherry
    Guerin, Annie
    Wu, Eric
    Bonifacio, Gaetano
    Cao, Xiting
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S314 - S315
  • [43] Real- world SEER-Medicare data analysis of the evolution of tumor characteristics, first-line therapies and overall survival (OS) in patients with neuroendocrine tumors (NETs)
    Schneider, M. D. P.
    Sinha, A.
    Dasari, A.
    Chan, J.
    Stoffels, A.
    Houchard, A.
    Paez-Pereda, M.
    JOURNAL OF NEUROENDOCRINOLOGY, 2023, 35 : 109 - 109
  • [44] Treatment Patterns and Outcomes in Patients with Myelodysplastic Syndromes Treated with Hypomethylating Agents: A SEER-Medicare Analysis
    Stein, Eytan M.
    Latremouille-Viau, Dominick
    Joseph, George J.
    Shi, Sherry
    Guerin, Annie
    Wu, Eric Q.
    Bonifacio, Gaetano
    Cao, Xiting
    BLOOD, 2019, 134
  • [45] Follicular Lymphoma Treatment Patterns and Outcomes over Time: A Real-World Analysis in the United States
    Phillips, Tycel
    Yu, Junhua
    Kamalakar, Rajesh
    Davies, Kalatu R.
    Mutebi, Alex
    Chawla, Savreet Bains
    Arnette, Donald
    Quadri, Syed
    Wang, Anthony
    BLOOD, 2022, 140 : 5241 - 5243
  • [46] Treatment of localized prostate cancer: A survival analysis using seer-Medicare data
    Wong, YN
    Wan, F
    Mitra, N
    Localio, R
    Montagnet, C
    Hudes, G
    Armstrong, K
    JOURNAL OF UROLOGY, 2006, 175 (04): : 212 - 212
  • [47] Real-World Treatment Patterns and Healthcare Expenditures in Patients With Surgically Resected Non-Small Cell Lung Cancer: A Population-based Analysis Using the SEER-Medicare Database
    Rajaram, R.
    Johnson, B.
    Huang, Q.
    Chandran, U.
    Wong, C.
    Laxmanan, B.
    Hasan, A.
    Johnston, S.
    Kalsekar, I.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [48] Treatment Patterns and Overall Survival Following Biomarker Testing in Real-World Advanced NSCLC Patients
    Barlesi, F.
    Paz-Ares, L.
    Page, D.
    Shewade, A.
    Lambert, P.
    Mughal, T.
    Gay, L.
    Khorshid, M.
    Arnieri, B.
    Capra, W.
    Foser, S.
    Mascaux, C.
    Bubendorf, L.
    Wang, L.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S459 - S460
  • [49] Real-world treatment patterns and overall survival among men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) in the US Medicare population
    Freedland, Stephen J.
    Davis, Matthew
    Epstein, Andrew J.
    Arondekar, Bhakti
    Ivanova, Jasmina I.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2024, 27 (02) : 327 - 333
  • [50] Real-world treatment patterns and overall survival among men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) in the US Medicare population
    Stephen J. Freedland
    Matthew Davis
    Andrew J. Epstein
    Bhakti Arondekar
    Jasmina I. Ivanova
    Prostate Cancer and Prostatic Diseases, 2024, 27 : 327 - 333
12345